Myriad Genetics Ending Patent Dispute on Breast Cancer Risk Testing
Tuesday, January 27, 2015 - 22:20
in Mathematics & Economics
The biotech company, the subject of a 2013 Supreme Court ruling that genes cannot be patented, said it was giving up trying to stop other companies from offering tests.